Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronic acid sodium composite gel for injection is a preclinical-stage aesthetic injectable developed by Haohai Healthcare Holdings. As a composite formulation, it likely combines sodium hyaluronate with other active ingredients or utilizes a specific cross-linking technology to enhance its properties as a dermal filler or skin booster. It is intended for use in medical aesthetics to address volume loss, wrinkles, or skin quality. In the Chinese market, such composite gels often incorporate components like lidocaine for comfort or specific amino acids and vitamins to promote skin rejuvenation alongside physical volumization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronic acid sodium composite gel for injection.